← back to search

Kangfeng Jin

Nantong University · CN
🔎 Find collaborators in Molecular Biology · Cancer Research →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Cancer Research
Research interest
Research focused on Hepatocellular carcinoma and Biomarker, with related work in Cancer research, Identification (biology), Wnt signaling pathway. Notable publications include 'Identification of serum tsRNA-Thr-5-0015 and combined with AFP and PIVKA-II as novel biomarkers for hepatocellular carcinoma', 'ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway', and 'Identification and potential mechanism of a novel gastric cancer suppressor tRF-24-6VR8K09LE9'.
h-index
citations
23
works
6
NIH funding
primary concept
email

Recent publications

Identification and potential mechanism of a novel gastric cancer suppressor tRF-24-6VR8K09LE9
Naunyn-Schmiedeberg s Archives of Pharmacology 2025cited by 4position: middledoi
Evaluation of serum hsa_tsr014055 as a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma
Annals of Medicine 2025cited by 2position: middledoi
TsR-0072 inhibits colorectal cancer progression through modulating lipid and vitamin D <sub>3</sub> metabolic reprogramming and inactivating the Wnt/β-catenin signalling pathway
Annals of Medicine 2025cited by 2position: middledoi
tRNA-Derived Small RNA Accelerates Tumorigenesis through Crosstalk with Tumor-Associated Macrophages, and Downregulation with Cell Membrane-Modified Polymer Nanoparticles Enables Treatment Response
ACS Applied Materials & Interfaces 2025cited by 2position: middledoi
Identification of serum tsRNA-Thr-5-0015 and combined with AFP and PIVKA-II as novel biomarkers for hepatocellular carcinoma
Scientific Reports 2024cited by 7position: firstdoi
ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway
Journal of Nanobiotechnology 2024cited by 6position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bairong Chen · Sun Yat-sen University5 papers (2024–2025)Hongyi Bao · Nantong University4 papers (2024–2025)Jinran Wu · Nantong University3 papers (2024–2025)Jing Xu · Shenzhen University3 papers (2024–2025)Feng Wei · Hebei Medical University3 papers (2025–2025)Feng Wang · Nantong Tumor Hospital3 papers (2025–2025)Lin Chen · Shanghai Jiao Tong University3 papers (2024–2025)Wei Zong · Nantong University2 papers (2024–2025)Yelan Tang · Nantong University1 papers (2025–2025)Jinran Wu · Nantong University1 papers (2024–2024)Linling Ju · Nantong University1 papers (2025–2025)Rongrong Jing · Nantong University1 papers (2025–2025)Kan Ni · Nantong University1 papers (2025–2025)Yixuan Wu · Fudan University1 papers (2024–2024)Qianyi Qi · Nantong University1 papers (2025–2025)Feng Wang · Shandong University of Traditional Chinese Medicine1 papers (2024–2024)Junling Yang · Nantong University1 papers (2024–2024)Feng Wang · Inner Mongolia University1 papers (2024–2024)Guang Zhu · The First Affiliated Hospital, Sun Yat-sen University1 papers (2024–2024)Guang Zhu · Xuzhou Medical College1 papers (2025–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Cancer Research →